Itron (ITRI) insider files Form 144 for 547 shares from vested stock
Rhea-AI Filing Summary
Form 144 notice for proposed sale of 547 shares of common stock, to be effected through Fidelity Brokerage Services on NASDAQ on 08/25/2025 with an aggregate market value of $68,542.99. The filing shows these 547 shares were acquired on 08/22/2025 through restricted stock vesting from the issuer and were recorded as compensation paid on 08/22/2025. The filing also discloses a prior sale by Donald Reeves of 529 shares on 05/27/2025 for gross proceeds of $60,805.96. The form lists total shares outstanding as 45,717,933. Several identifying fields for the filer and issuer (CIK, issuer name and contact details) are blank in the provided content.
Positive
- Acquisition method disclosed: shares were acquired through restricted stock vesting, recorded as compensation on 08/22/2025
- Planned sale size is very small relative to the reported 45,717,933 shares outstanding, suggesting limited market impact
Negative
- Missing issuer and filer identifiers: key fields such as filer CIK and issuer name/address are blank in the provided content
- Recent related sales: the filing shows a prior sale of 529 shares on 05/27/2025, indicating multiple small dispositions in the past few months
Insights
TL;DR: Small, routine insider sale from recent vested compensation; not material relative to outstanding shares.
The notice documents a proposed sale of 547 shares acquired through restricted stock vesting and designated as compensation, scheduled for 08/25/2025 via Fidelity on NASDAQ with an aggregate value of $68,542.99. Compared with the reported 45,717,933 shares outstanding, the sale represents a de minimis percentage of the float. The filing also records a recent sale of 529 shares on 05/27/2025 for $60,805.96, indicating modest, recurring dispositions rather than a large liquidation event.
TL;DR: Form contains required transaction details but lacks key filer/issuer identifiers, reducing transparency.
The submission includes transaction dates, acquisition method (restricted stock vesting), broker name and address, and amounts. However, several required identifying fields such as the filer CIK and issuer name/address are not populated in the provided content. That omission complicates independent verification and regulatory tracking and should be addressed in the official filing record.
FAQ
What does the Form 144 filed for ITRI report?
How were the 547 shares acquired according to the filing?
Has the seller made other sales recently?
What is the total number of shares outstanding reported in the form?
Are there any deficiencies in the provided Form 144 content?